Skip to main content
Clinical Trials/IRCT20191008045024N1
IRCT20191008045024N1
Recruiting
Phase 3

Effect of oral probiotic supplements on cognitive status, activity of daily living (ADL) and metabolic index in demented elderly: A randomized, double-blind, placebo-controlled trial

Tehran University of Medical Sciences0 sites68 target enrollmentTBD

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Condition 1: Dementia. Condition 2: Alzheimer's disease.
Sponsor
Tehran University of Medical Sciences
Enrollment
68
Status
Recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients aged 60 and older
  • According to the 2011NIA\-AA criteria for dementia in the mild to moderate stage
  • Obtaining informed consent

Exclusion Criteria

  • Chronic infections
  • Consumption any products that contain probiotics or prebiotics during the recent 6 months
  • Taking any kind of antibiotics during the month before starting the study
  • History of any severe gastrointestinal diseases including celiac disease, inflammatory bowel diseases and diverticulitis or gastrointestinal surgery
  • Alcohol consumption during 1 month before
  • Suffering from severe heart disease, severe renal or liver impairment
  • Patients with frontotemporal dementia (FTD), dementia with Lewy bodies (DLB), Parkinson’s disease dementia (PDD) and any demented patients in severe stage, are also excluded because of their different nature and progression manner
  • Occurrence of delirium at the beginning of the study

Outcomes

Primary Outcomes

Not specified

Similar Trials